The Discounted Cash Flow (DCF) valuation of Johnson & Johnson (JNJ) is 158.20 USD. With the latest stock price at 156.90 USD, the upside of Johnson & Johnson based on DCF is 0.8%.
Based on the latest price of 156.90 USD and our DCF valuation, Johnson & Johnson (JNJ) is a buy. buying JNJ stocks now will result in a potential gain of 0.8%.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 7.7% | 6.8% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 105.61 - 315.11 | 158.20 |
| Upside | -32.7% - 100.8% | 0.8% |